Distribution of culprit lesions in patients with ST-segment elevation acute myocardial infarction treated with

M Louisa Antoni1, Kai-Hang Yiu, Jael Z Atary

  • 1Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

Coronary Artery Disease
|September 28, 2011
PubMed

Insights

Vulnerable plaque in ST-segment elevation acute myocardial infarction most often occurs in the left anterior descending artery. Lesion location impacts cardiac enzyme levels and left ventricular function, highlighting the need to identify high-risk patients.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biomedical Imaging

Background:

  • Limited data exists on the distribution of vulnerable coronary artery lesions.
  • Understanding lesion location is crucial for managing acute myocardial infarction (AMI).

Purpose of the Study:

  • To determine the frequency and distribution of culprit lesions in ST-elevation myocardial infarction (STEMI) patients.
  • To correlate culprit lesion location with infarct size.

Main Methods:

  • Evaluation of 1533 consecutive STEMI patients undergoing primary percutaneous coronary intervention.
  • Two-dimensional echocardiography performed within 48 hours of admission.

Main Results:

  • Culprit lesions were most frequent in the left anterior descending (LAD) artery (45%), followed by the right coronary artery (RCA, 38%) and left circumflex (LCX) artery (14%).
  • Proximal LAD and LCX lesions correlated with higher peak cardiac enzymes and worse left ventricular function compared to RCA lesions.
  • Proximal LAD and LCX lesions were associated with worse left ventricular function.

Conclusions:

  • Plaque rupture leading to AMI commonly affects proximal LAD and RCA segments.
  • Culprit lesion location influences infarct size and clinical outcomes.
  • Identifying vulnerable lesion distribution aids in risk stratification for acute coronary events.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...